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Abstract Infection with the food-borne liver fluke Opisthorchis viverrini is the principal risk
factor (IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012) for
cholangiocarcinoma (CCA) in the Lower Mekong River Basin countries including Thailand, Lao PDR,
Vietnam and Cambodia. We exploited this link to explore the role of the secreted growth factor
termed liver fluke granulin (Ov-GRN-1) in pre-malignant lesions by undertaking programmed
CRISPR/Cas9 knockout of the Ov-GRN-1 gene from the liver fluke genome. Deep sequencing of
amplicon libraries from genomic DNA of gene-edited parasites revealed Cas9-catalyzed mutations
within Ov-GRN-1. Gene editing resulted in rapid depletion of Ov-GRN-1 transcripts and the
encoded Ov-GRN-1 protein. Gene-edited parasites colonized the biliary tract of hamsters and
developed into adult flukes, but the infection resulted in reduced pathology as evidenced by
attenuated biliary hyperplasia and fibrosis. Not only does this report pioneer programmed gene-
editing in parasitic flatworms, but also the striking, clinically-relevant pathophysiological phenotype
confirms the role for Ov-GRN-1 in virulence morbidity during opisthorchiasis.
DOI: https://doi.org/10.7554/eLife.41463.001
Introduction
Liver fluke infection caused by species of Opisthorchis and Clonorchis remains a major public health
problem in East Asia and Eastern Europe. O. viverrini is endemic in Thailand and Laos, where ~10
million people are infected with the parasite (Sripa et al., 2011). In liver fluke endemic regions, this
infection causes hepatobiliary morbidity including cholangitis, choledocholithiasis (gall stones), and
periductal fibrosis, and is the principal risk factor for bile duct cancer, cholangiocarcinoma (CCA)
(Sripa et al., 2011; Sripa et al., 2007; Mairiang et al., 2012; Tyson and El-Serag, 2011; Shin et al.,
2010a). Indeed, there is no stronger link between a human malignancy and a parasitic infection than
that between CCA and infection with O. viverrini (Pagano et al., 2004). Northeastern Thailand suf-
fers the highest incidence of CCA in the world, often exceeding 80 cases per 100,000 population
and for which up to 20,000 people annually are admitted for surgery. The prognosis for liver fluke
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infection-induced cancer remains poor (Sripa et al., 2011; Khuntikeo et al., 2015; Khuntikeo et al.,
2016; Luvira et al., 2016).
How and why opisthorchiasis induces cholangiocarcinogenesis is likely multi-factorial, including
mechanical irritation of the biliary tract during migration and feeding of the liver fluke, secretion by
the parasite of inflammatory molecules, and nitrosamines in fermented foods that are a dietary sta-
ple in northeastern provinces of Thailand (Songserm et al., 2012). To survive in the hostile host envi-
ronment, parasitic helminths produce an assortment of excretory/secretory (ES) products including
proteins with diverse roles at the host–parasite interface. This interaction has long been thought, but
not fully understood, to modify cellular homeostasis and contribute to malignant transformation dur-
ing chronic opisthorchiasis (Brindley and Loukas, 2017). Feeding activity of the liver fluke inflicts
wounds in the biliary tree, resulting in lesions that undergo protracted cycles of repair and re-injury
during chronic infection. The liver fluke secretes mediators that accelerate wound resolution in
monolayers of cultured cholangiocytes, an outcome that is compromised following silencing of
expression of the liver fluke secreted growth factor Ov-GRN-1 using RNA interference
(Papatpremsiri et al., 2015; Smout et al., 2015). We hypothesize that proliferation of biliary epithe-
lial cells induced by Ov-GRN-1 is a pivotal factor in maintenance and progression of a tumorigenic
microenvironment in the liver during chronic opisthorchiasis.
Progress with development of genetic tools for functional genomic studies with platyhelminth
parasites has been limited to date (Hoffmann et al., 2014). The use of clustered regularly inter-
spaced short palindromic repeats (CRISPR) associated with Cas9, an RNA-guided DNA endonucle-
ase, has revolutionized genome editing in biomedicine, agriculture and biology (Hsu et al., 2014;
Sander and Joung, 2014). Progress with CRISPR/Cas9 in numerous eukaryotes including the nemat-
odes Caenorhabditis elegans, Strongyloides stercoralis and Strongyloides ratti has been described
(Sander and Joung, 2014; Waaijers and Boxem, 2014; Lok et al., 2017; Gang et al., 2017), but
this form of gene editing has not been reported for flatworm parasites. Here, we deployed a
CRISPR/Cas9-based approach, aiming to knockout (mutate) the Ov-GRN-1 gene and assess the viru-
lence of gene-edited flukes in vitro and in vivo in a hamster model of opisthorchiasis.
eLife digest In the rural regions alongside the Mekong River in South East Asia, traditional
cuisines often use uncooked or under cooked fish, many of which carry a worm known as
Opisthorchis viverrini. Once inside the body, this parasite settles in the human liver, causing a
tropical disease known as liver fluke infection. Out of the 10 million people affected by O. viverrini,
thousands will also develop a type of liver cancer that is triggered by the presence of the worm. In
particular, the parasite secretes a protein known as granulin that may encourage certain liver cells to
multiply, potentially raising the risk for cancer.
A gene editing technique called CRISPR/Cas9 allows scientist to precisely target and then
deactivate the genetic information a cell needs to produce a given protein. While the tool has been
used in other species before, it was unknown if it could be applied to O. viverrini. Here, Arunsan
et al. harnessed CRISPR/Cas9 to deactivate the gene that codes for granulin and create parasites
that can only produce very little of the protein.
Hamsters infected with the gene-edited worms had fewer symptoms of liver fluke infection
compared to those carrying normal O. viverrini. The animals with parasites that cannot produce
granulin also had fewer changes to the liver that are associated with cancer. These findings confirm
that granulin has a role in promoting liver fluke infection and liver cancer.
Alongside this work, Ittiprasert et al. used CRISPR/Cas9 to inactivate a gene in a species of worm
that causes a human disease called schistosomiasis. Together, these findings demonstrate for the
first time that the gene editing method can be adapted for use in parasitic worms, which are a major
public health problem in tropical climates. This tool should help scientists understand how the
parasites invade and damage our bodies, and provide new ideas for treatment and disease control.
DOI: https://doi.org/10.7554/eLife.41463.002
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Results
Programmed mutation of growth factor secreted by carcinogenic liver
fluke
Following transfection of adult flukes with the gene-editing construct targeting Ov-GRN-1, the activ-
ity and efficiency of programmed editing was evaluated by two approaches. First, quantitative PCR
(qPCR) was employed, which relies on the inefficiency of binding of a primer (here termed OVR-F)
overlapping the target genomic sequence of the guide RNA (gRNA), that is where mutations are
expected to have occurred, compared to the binding efficiency of flanking primers, that is outside
the mutated region (flanking primers termed OUT-F and OUT-R) (Figure 1A and B). The ratio
between the OVR-F and OUT-R products and OUT-F and OUT-R products provided an estimate of
the amplification fold-reduction in the sample of CRISPR/Cas9-edited compared to genomic DNA
(gDNA) from control, wild-type liver flukes at the target sequence of the sgRNA, that is the anneal-
ing site for the OVR primer (Shah et al., 2015; Yu et al., 2014). A reduction in relative fold amplifi-
cation of 2.7% was detected in gDNA from the Cas9-treated worms (Figure 1E, Figure 1—figure
supplement 1C). Second, to identify, quantify and characterize the mutations that arose in the
genome of Ov-GRN-1-edited (termed DOv-GRN-1) flukes, we used an amplicon-sequencing
approach. A targeted (amplicon) sequence library was constructed from gDNA from some of the
flukes (7 to 21 days after pCas-Ov-GRN-1 transfection). A fragment of 173 bp spanning the pre-
dicted site of the programmed double stranded break of Ov-GRN-1 was amplified from gDNA
primed with oligonucleotides flanking 1496–1668 nt of Ov-GRN1. Adaptors and barcodes were
ligated into the amplicon libraries. Deep sequencing of the amplicon libraries was undertaken using
the Illumina MiSeq system. Insertion-deletion (INDEL)/mutation profiles in the sequence reads were
compared in multiple sequence alignments with the reference template sequence, nt 1,496–1,668 of
wild type Ov-GRN-1. The CRISPResso computational pipeline was used to quantify gene-editing out-
comes and efficiency (Canver et al., 2018; Pinello et al., 2016); among >2 million reads aligned
against the reference sequence, 27,640 sequence reads exhibited non-homologous end joining
(NHEJ) mutations, including 170 reads with insertions (0.6%), 193 reads with deletions (0.7%) and
27,277 reads with substitutions (98.7%). Overall, 1.3% of the sequenced reads exhibited NHEJ muta-
tions (Figure 1C). Regarding the NHEJ-bearing reads,>100 forms exhibited mutations that would
disrupt the coding sequencing of Ov-GRN-1. Four representatives of the INDEL-bearing traces,
aligned with the wild type (WT) allele are presented in Figure 1—figure supplement 1B. These and
related (below) sequence reads are available at GenBank Bioproject PRJNA385864, Biosample
SAMN07287348, SRA study SRP110673, accessions SRR5764463-5764618 and SRR8187484-
SRR8187487, at https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP110673, Bioproject, www.ncbi.
nlm.nih.gov/bioproject/PRJNA385864.
Diminished proliferation and wound healing induced by excretory/
secretory products of genome-edited liver flukes
Effects of gene editing on transcription and protein expression in adult flukes were investigated. Lev-
els of both Ov-GRN-1 mRNA transcripts as determined by reverse transcription (RT)-qPCR and of
Ov-GRN-1 protein, as detected by western blot using anti-Ov-GRN-1 serum, fell significantly from
days 1 and 2 after transfection, respectively (p0.0001; Figure 1D and E, Figure 1—figure supple-
ment 1C). Expression levels of two reference genes encoding actin (Figure 1—figure supplement
1C) and the Ov-TSP-2 tegument protein (Figure 1D) were not influenced by the programmed muta-
tion of Ov-GRN-1. These findings, revealing diminished RNA and protein following programmed
mutation indicated that CRISPR/Cas9 catalyzed programmed gene-editing of Ov-GRN-1 was active
in adult flukes in vitro. Thereafter, to investigate whether gene editing of Ov-GRN-1 impacted in
vitro indicators of pathogenesis, the capacity of ES products from WT, mock-transfected and gene-
edited flukes to drive proliferation and scratch wound repair of the H69 human cholangiocyte cell
line was assessed. ES from WT and mock-transfected adult flukes stimulated cell proliferation and
wound closure whereas an equivalent amount of ES products from DOv-GRN-1 flukes resulted in sig-
nificantly reduced cell proliferation over the 6-day course of the assay (p  0.0001; Figure 2A and B,
Figure 2—figure supplement 1A and B) and significantly reduced in vitro wound closure over 36 hr
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Figure 1. CRISPR/Cas9-mediated gene editing strategy to knockout Ov-GRN-1 in the adult developmental stage of the O. viverrini liver fluke. (A)
Schematic depiction of Ov-GRN-1 gene with CRISPR/Cas9 target site in first exon marked with green arrow. (B) The exon1, 2 and 3 location of Ov-GRN-
1 gene, size of 6267 bp and gRNA targeting exon 1: gRNA sequence is highlighted in blue and the PAM (CGG) in parenthesis in red. Primer pairs were
used to detect levels of mRNA expression using a RT-qPCR assay (Ov-GRN-1 RT- forward or RT-F and Ov-GRN1 RT-reverse or RT-R), Tri-primers were
Figure 1 continued on next page
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(p  0.0001; Figure 2C and D, Figure 2—figure supplement 1C and D), consistent with the reduc-
tion in Ov-GRN-1 protein secreted from the gene-edited liver flukes.
Attenuated infection-induced hyperplasia of the biliary tract
Notwithstanding the marked effects observed with gene-edited, adult developmental forms, the
metacercaria (MC) (Figure 3A) is the infective stage of O. viverrini for humans. Accordingly, we
investigated gene knockout in MC. Significant differences in Ov-GRN-1 transcript levels were noted
between groups of MC (p  0.01), but the effect was modest, 4%, at each time point (Figure 3—
figure supplement 1), suggesting that delivery of the pCas-Ov-GRN-1 by electroporation through
the MC cyst wall was ineffective. Exposure to bile acids and gastric enzymes results in excystation of
O. viverrini MC in the duodenum of the mammalian host (Sripa et al., 2011). Using trypsin, here the
process was mimicked in vitro to release the newly excysted juvenile worms (NEJ) (Figure 3B), after
which these NEJs were subjected to electroporation with the CRISPR/Cas9 plasmid construct, in like
fashion to the adult developmental stage of O. viverrini (above). Following this manipulation, marked
depletion of Ov-GRN-1 transcripts in NEJ was evident by 24 hr later (p  0.0001) (Figure 3C).
In parallel, hamsters were infected with 100 DOv-GRN1 NEJs or WT NEJs immediately after elec-
troporation. At necropsy of the hamsters 14 days later, similar numbers of WT and DOv-GRN-1
flukes were observed in the bile ducts, and they were similarly motile (not shown). Strikingly, how-
ever, acute infection with DOv-GRN-1 parasites failed to induce the marked hyperplasia of the biliary
epithelia characteristic of chronic opisthorchiasis. Specifically, infection with WT flukes induced
markedly disordered, hyperplasic growth of the epithelium adjacent to the parasites; ~500% thicken-
ing of the biliary epithelium compared to uninfected controls as measured in two-dimensional image
analysis of H and E-stained thin sections (p  0.0001). By contrast, infection with the DOv-GRN-1
flukes provoked significantly less (p  0.0001) biliary hyperplasia than WT flukes (145% thickening
compared to uninfected controls; p  0.01). Indeed, the bile ducts from hamsters infected with the
DOv-GRN-1 flukes generally resembled those of the uninfected control hamsters (Figure 3D–G). At
60 days after infection, significant differences in biliary hyperplasia remained between hamsters
infected with WT (216%) and DOv-GRN-1 (162%) flukes (p  0.05), although this was less marked
than during acute infection at day 14 (Figure 3G).
Reduced periductal fibrosis and morbidity during chronic
opisthorchiasis
To evaluate disease during chronic infection with DOv-GRN-1 liver flukes and associated chronic bili-
ary morbidity, hamsters were infected with DOv-GRN-1 and WT NEJ, and adult flukes were recov-
ered and counted from the livers 60 days post-infection. Similar numbers of worms were recovered
from both control and gene-edited liver fluke-infected hamsters (Figure 4A). To assess the impact of
infection with DOv-GRN-1 on markers of chronic opisthorchiasis including biliary fibrosis, liver
Figure 1 continued
used to detect the % relative fold amplicon or mutations (outside-forward or OUT-F, overlap-forward or OVR-F and reverse primer or OUT/OVR-R) and
MiSeq forward and reverse (MiSeq-F and MiSeq-R) primers were used to prepare the NGS amplicon. (C) CRISPR/Cas9-catalyzed insertion (red bars) and
deletion (black bars) mutations (INDELs) detected in the Ov-GRN-1 gene; target site of programmed CRISPR/Cas9 double strand break indicated by
the green arrow. Average mutation length was plotted against Ov-GRN-1 gene amplicon position in base pairs (bp). (D) Somatic tissues of individual
adult worms (in triplicate per time per group) were solubilized, electrophoresed in SDS-PAGE gels, transferred to nitrocellulose membrane and probed
with anti-Ov-GRN-1 rabbit antibody. WT: wild-type control fluke tissues; D1 to 21: DOv-GRN-1 fluke tissues sampled the arrow highlighting the ~9 kDa
Ov-GRN-1 band at increasing time points (days) following transfection and DOv-GRN-1 flukes showed similar levels of expression of Ov-TSP-2 protein
(control antibody). D1 to 21, protein products from flukes days 1 to 21 following gene-editing treatment. Western blot strips probed with rabbit anti-
Ov-TSP-2 antiserum, the arrow highlighting the band at ~24 kDa representing Ov-TSP-2. (E) Reduced levels of Ov-GRN-1 transcripts and Ov-GRN-1
protein after transfection of adult flukes with Ov-GRN-1 CRISPR/Cas9 construct using quantitative real-time PCR (mRNA) and densitometry of western
blot signals (protein). Data were plotted relative to wild type (WT) fluke values (100%) as the mean ±SD of three replicates. ****p < 0.0001 compared to
levels in WT flukes - protein in black; RNA in pink - at each time point (two-way ANOVA Holm-Sidak multiple comparison test).
DOI: https://doi.org/10.7554/eLife.41463.003
The following figure supplement is available for figure 1:
Figure supplement 1. CRISPR/Cas9 targeting Ov-GRN-1 design and fluke transfection.
DOI: https://doi.org/10.7554/eLife.41463.004
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Figure 2. ES products of DOv-GRN-1 adult flukes induced less cell proliferation and wound repair in vitro. (A) Representative cell proliferation images
of H69 cholangiocyte cells co-cultured with flukes in Transwell plates; mock transfected (top) and DOv-GRN-1 (bottom) groups shown at day 3. (B)
Reduced cell proliferation induced by ES products of DOv-GRN-1 fluke, as shown in panel (A), quantified from days 1 to 6. Data were plotted as mean
relative percentage to control cells cultured in the absence of flukes. (C) Representative image of repair of wound from scratch in cultured H69 scratch
during co-culture with flukes in Transwell plates. Mock transfected (upper) and DOv-GRN-1 (lower) groups shown at 0 and 36 hr after scratch wounding.
Dotted line indicates the margin of the wound. (D) Scratch wound repair assay quantified from 0 to 36 hr, revealing diminished healing in cells co-
cultured with the DOv-GRN-1 parasites. Panels (B) and (D): mean ±SD, three replicates; ****p < 0.0001 compared to wild-type flukes with two-way
ANOVA Holm-Sidak multiple comparison test.
DOI: https://doi.org/10.7554/eLife.41463.005
The following figure supplement is available for figure 2:
Figure supplement 1. Extended set of images showing DOv-GRN-1 adult fluke ES products induce less in vitro cell proliferation and wound repair.
DOI: https://doi.org/10.7554/eLife.41463.006
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Figure 3. Gene edited DOv-GRN-1 newly excysted juveniles infected hamsters but drove reduced acute pathogenic lesions. Micrographs of
metacercariae (A) and newly excysted juvenile flukes (NEJ) (B). (C) Levels of Ov-GRN-1 transcripts in mock-transfected and DOv-GRN-1 flukes at one to
five days as quantified with qPCR and plotted relative to the wild type (WT) untreated group; mean ±SD; three replicates; ****p  0.0001 compared to
WT flukes with two-way ANOVA Holm-Sidak multiple comparison test at each time point. (D) Representative micrograph (200  magnification) of H&E-
Figure 3 continued on next page
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sections from infected hamsters were stained with Picro-Sirius Red to localize collagen bundles in
the biliary tract (Figure 4B). Minimal deposits of collagen were seen in the periductal regions of the
biliary tract of the uninfected control hamsters. By contrast, thick bands of collagen surrounded the
enlarged bile ducts in the vicinity of the flukes in the hamsters infected with WT parasites. Signifi-
cantly less collagen (28%) had been deposited in periductal regions of hamsters infected with DOv-
GRN-1 flukes compared to livers of hamsters infected with WT flukes (p  0.001) (Figure 4B and C).
To further assess fibrosis, thin sections of livers were immuno-stained for alpha-smooth muscle actin
(a-SMA or ACTA2), a marker of hepatic fibrosis (Guido et al., 1997). Livers of hamsters infected
with WT flukes showed densely packed collagen fibrils that stained for ACTA2 in periductal regions
proximal to the parasites. In contrast, livers from hamsters infected with DOv-GRN-1 flukes displayed
an irregular distribution of less dense collagen fibrils with less ACTA2-specific fluorescence
(Figure 4D, Figure 4—figure supplement 1). Measuring Alexa-594 fluorescence quantified the
expression levels of ACTA2. Median levels of ACTA2 (quantified using Alexa-594-anti-ACTA2) in the
livers of DOv-GRN-1 fluke-infected hamsters were significantly reduced (94%) compared to those of
WT fluke-infected hamsters (p  0.01) (Figure 4E).
Gene editing efficiency correlated negatively with granulin gene
expression
Bile ducts parasitized by the gene-edited worms displayed a broad range of fibrosis from minimal to
marked, as established by staining both with Sirius Red and with antibody specific for alpha-smooth
muscle actin. This situation may have reflected unevenness in level of programmed mutation of the
Ov-GRN-1 gene in cells within and/or among individual liver flukes. To investigate this situation fur-
ther, we assessed transcription of the Ov-GRN-1 gene from individual adult flukes recovered from
hamsters 60 days after infection with gene edited NEJ. This revealed that levels of Ov-GRN-1 mRNA
in the DOv-GRN-1 group flukes were 81% lower, in aggregate, than the control wild-type flukes
(Figure 5A). Thereafter, to evaluate the mutation rate of the gene editing approach, which involved
transfection by electroporation of batches of 750 NEJs, adult flukes at necropsy were assigned to
one of three groups based on Ov-GRN-1 mRNA expression levels, as follows: (i)  100% relative to
WT mean, that is, low (L) efficiency of programmed gene editing; group was termed LDOv-GRN-1;
(ii) > 10 to<100% relative to WT mean, that is moderate (M) level efficiency of programmed gene
editing; termed MDOv-GRN-1; and (iii)  10% relative to WT mean, that is high (H) level efficiency of
programmed gene editing; termed HDOv-GRN-1. Genomic DNAs pooled from 7 to 10 worms of
each group were studied to quantify the efficiency of gene editing, using both the NGS CRISPResso
and the tri-primer qPCR approaches. The NGS CRISPResso analysis revealed mutation rates of 1.3,
5.9 and 17.2% in the L, M, and H groups of DOv-GRN-1 worms, respectively. The tri-primer qPCR
analysis indicated mutation levels of 0.7, 3.2 and 4.6% in these groups, respectively. Both
approaches confirmed that the efficiency of programmed gene editing negatively correlated with
levels of the Ov-GRN-1 transcripts (Figure 5A and B). The combined mutation frequency among all
three groups by the two approaches was 8.1% and 2.7%, with the 2.7% rate estimated by tri-primer
qPCR indicating the same level as the mutation rate of 2.7% observed during culture of adult stage
DOv-GRN-1 flukes for 7 to 21 days in vitro (Figure 1E, Figure 1—figure supplement 1C). In
Figure 3 continued
stained thin sections from livers of hamsters at 14 days after infection with WT flukes. (E) Representative micrograph of H&E-stained thin sections
showing hamster liver 14 days after infection with DOv-GRN-1 flukes. (F) Representative micrograph of H&E stained thin sections of livers of control,
uninfected hamsters, revealing the healthy, organized pavement-like profile of the cells of the biliary epithelium (BE) enclosing the lumen of the bile
duct (BD), near a blood vessel (BV), within the liver (L). Infection by WT flukes (D) revealed thickened, disordered epithelium adjacent to the parasite
(Ov). Infection with the gene edited DOv-GRN-1 flukes (E) revealed a bile duct epithelium more similar to the uninfected hamster. (G) Epithelium width/
hyperplasia (green bracket) was quantified using ImageJ and plotted as the mean ±SD of five biological replicates (hamsters) from each of group and
time point (14 and 60 days). Significant differences were apparent when compared to the uninfected group using the two-way ANOVA with Holm-Sidak
multiple comparison test: **p  0.01 and ****p  0.0001, and wild-type compared to DOv-GRN-1, #p  0.05 and ####p  0.0001.
DOI: https://doi.org/10.7554/eLife.41463.007
The following figure supplement is available for figure 3:
Figure supplement 1. CRISPR/Cas9 ineffective at silencing gene expression in metacercariae (MC).
DOI: https://doi.org/10.7554/eLife.41463.008
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Figure 4. Reduced fibrosis during chronic infection of hamsters with gene-edited DOv-GRN-1 liver flukes. (A) Adult fluke numbers were counted from
the livers of necropsy at 60 days post-infection and presented as the average and range for two hamsters per group. Numbers of flukes were similar in
the wild type (WT) and DOv-GRN-1 groups; non-significant (ns). (B) Representative micrographs of thin sections of Sirius red-stained liver (L) from
uninfected hamsters revealed minimal deposition of collagen (fibrosis [fb]) in the periductal regions and adjacent liver parenchyma; a thin margin of
Figure 4 continued on next page
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addition, the NGS CRISPResso analysis of the sequence reads of the gene-edited L, M and H groups
compared with those from the control WT group (GenBank accessions SRR8187484-SRR8187487, 5
to 10 million reads per targeted amplicon library) provided details of the nature and types of the
mutations as insertions, deletions and/or substitutions following NHEJ events that repaired the pro-
grammed cleavage of the Ov-GRN-1 locus. The analysis also revealed increasing ratio of substitu-
tions among the mutations among the LDOv-GRN-1, MDOv-GRN-1 and HDOv-GRN-1 groups
(Figure 5B). Lastly, these findings also demonstrated the longevity of the programmed mutation at
Ov-GRN-1; mutations were retained in the parasite for at least 60 days during active infection of the
mammalian host.
Discussion
This report, and the accompanying article on schistosomes (Ittiprasert et al., 2019), pioneer pro-
grammed gene editing using CRISPR/Cas9 of trematodes and indeed genome editing for species of
the phylum Platyhelminthes. The findings revealed that somatic tissue gene editing disrupted the
expression of liver fluke granulin, resulting in a clinically noteworthy phenotype of attenuated hepa-
tobiliary tract morbidity. Scrutiny of the nucleotide sequence reads indicated that the chromosomal
break took place as programmed and was repaired subsequently by NHEJ following Cas9-catalyzed
mutation (Albadri et al., 2017). Accordingly, the findings confirmed that the bacterial Type II Cas9
system is active in O. viverrini, and we suggest that Cas9-mediated programmed gene editing and
repair by homology directed repair and NHEJ will be active in other genes of the liver fluke, and in
other trematodes and parasitic platyhelminths generally.
Although the findings demonstrated programmed gene editing of the Ov-GRN-1 locus, the
somatic mutation rate in the adult developmental stage was generally <5% of the genomes recov-
ered from these multicellular parasites. This low mutation rate contrasted with both the marked
reduction in Ov-GRN-1 message detected in vitro and the pathophysiological outcomes and
reduced virulence of infection of hamsters with gene-edited flukes. The anomaly might be explained
Figure 4 continued
red-stained material outlined the endothelial cells of the blood vessel (BV) walls, and the biliary epithelia (BE) of the bile ducts (BD). Livers from
hamsters infected with WT flukes (Ov) included marked deposition of collagen with elongated BE cells adjacent to the flukes. There was substantial
collagen deposition in livers of hamsters infected with DOv-GRN1 flukes compared to uninfected liver sections but far less than for hamsters infected
with WT flukes. (C) Liver fibrosis quantified with ImageJ MRI-fibrosis plugin presented as violin plots: 100 images containing bile ducts from 20 sections
(five hamsters) per group; mean (black dot)±SD (vertical line). Fibrosis was reduced in the DOv-GRN-1 (23% less) compared to WT fluke-infected
hamsters. The width of the violin plot represents measurement frequency. The Kruskal-Wallis with Dunn’s multiple comparisons test was used to
compare groups against the uninfected hamsters: ****p  0.0001; and DOv-GRN-1 against WT, ###p  0.001. (D) Representative micrographs,
immunofluorescence/bright-field overlays, of sections probed with anti-ACTA2 antibody with fluorescence intensity indicated on a blue/green/red
scale. ACTA2 was universally detected in myofibroblasts surrounding BV but not detected adjacent to healthy uninfected BD. The proximity of ACTA2
to fluke-infected BD was suggestive of myofibroblast generation in response to fluke-induced damage to BE. The upper row of micrographs (overlay)
present combined bright-field and anti-ACTA2 fluorescence wide views of the liver sections. The boxed regions in the upper row indicate informative
sites, which have been magnified and expanded in the central and lower rows of micrographs. The central row presents the boxed region with anti-
ACTA2 fluorescence alone (Zoom Anti-ACTA2) and lower row presents the bright-field image overlaid by the fluorescence field (Zoom Overlay). Liver
sections exhibited intense fluorescence surrounding BV (arterial blood vessels: red/green, venous vessels: blue/green), whereas in livers of uninfected
hamsters BD exhibited only minimal fluorescence. The highlighted magnified (Zoom) rows of images revealed WT infected livers expressing mild (blue)
but steady levels of ACTA2-staining surrounding thickened BE layer. The inner and outer BE cell margins are indicated by the dotted line (orange)
around BDs with WT flukes. Livers from hamsters infected with DOv-GRN1 flukes showed irregular, generally feeble expression of ACTA2 proximal to
BD. (E) Quantified levels of ACTA2 signals surrounding BDs from sections of hamster livers. Violin plot with reverse log2 Y-axis showing the ACTA2
intensity (per cm2 at 300 PPI) adjacent to BE, established from 25 to 30 discrete BD images per group (three hamsters), as assessed with ImageJ. Zero
values from the uninfected group were deemed to have a value of 1 in order to plot the log axis. SD indicated as a line with the mean indicated by the
central black dot, and the width of the violin indicative of frequency of measurement. ACTA2 staining showed 94% median reduction in DOv-GRN-1
fluke-infected livers compared to hamsters infected with WT liver flukes. One-way ANOVA with Holm-Sidak multiple comparison test, ****p  0.0001
compared to uninfected and ##p < 0.01 compared to DOv-GRN1 flukes against WT flukes.
DOI: https://doi.org/10.7554/eLife.41463.009
The following figure supplement is available for figure 4:
Figure supplement 1. Representative wide-angle view of anti-ACTA2 immunofluorescence and bright field liver sections.
DOI: https://doi.org/10.7554/eLife.41463.010
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Figure 5. Characterization of gene knockout mutations in adult liver flukes from hamsters chronically infected hamsters. Expression of Ov-GRN-1
transcripts was reduced in DOv-GRN-1 compared to WT flukes. (A) Reverse log10 Y-axis shows the qPCR 2
(-DDCt) findings from flukes 60 days after
programmed CRISPR/Cas9-gene editing and hamster infection plotted relative to mean value for the WT infection. The WT group displayed a broad
level of expression, whereas the mean expression level for the DOv-GRN-1 flukes was only 19.4% of the WT group; Mann-Whitney nonparametric test,
**p  0.01. Although significantly lower as a group, individual worms of this DOv-GRN-1 cohort displayed phenotypes that ranged from no apparent
effect (wild-type phenotype) to markedly diminished expression of Ov-GRN-1 (DOv-GRN-1 phenotype). Mutation frequency was assessed by assigning
worms in the DOv-GRN-1 group into three sub-groups of flukes based on CRISPR/Cas9 mutation frequency. Eight flukes with effective CRISPR gene
knockout (HDOv-GRN1: Ov-GRN-110% expression), seven flukes with modest levels of transcript knockout (MDOv-GRN-1:>10 to<100% Ov-GRN-1),
and 10 flukes exhibiting little or no effect (LDOv-GRN-1: Ov-GRN-1 100–120%). The aggregate mutation frequency among the three DOv-GRN-1 sub-
groups was 8.1% and 2.7% as estimated by the NGS-CRISPResso and tri-primer qPCR approaches, respectively. (B) Pie charts showing the CRISPResso
estimated rate of programmed mutations in the LDOv-GRN-1, MDOv-GRN-1 and HDOv-GRN1 sub-groups compared to non-mutated, WT reads. NHEJ
mutation rate indicated by the pie slice (navy blue) and the proportion of each mutation sub-type is provided on the expanded bar at the right.
DOI: https://doi.org/10.7554/eLife.41463.011
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by the tissue expression of secreted Ov-GRN-1. Although it exhibits generalized expression through-
out tissues of the adult liver fluke, predominant expression of Ov-GRN-1 has been immunolocalized
to the tegumental surface, tegumental cytons and gut (Smout et al., 2009). Given that the flukes
were transfected in vitro with the gene editing plasmid by square wave electroporation, gene knock-
out of the target Ov-GRN-1 locus in nuclei of cells in the tegument and gut may have occurred more
frequently than in cells deeper within the fluke. If so, this may explain the marked reduction of
expression and secretion of Ov-GRN-1 in tandem with a limited rate of mutation estimated in geno-
mic DNA pooled from the gene-edited flukes.
The activity in vitro of liver fluke granulin in cell proliferation, wound repair and angiogenesis has
been established (Papatpremsiri et al., 2015; Smout et al., 2015; Smout et al., 2009), which has
prompted the development of therapeutic peptides based on the Ov-GRN-1 scaffold for treatment
of non-healing wounds (Bansal et al., 2017; Dastpeyman et al., 2018). The novel findings reported
here corroborate earlier in vitro reports and extend the findings in a rodent model of human opis-
thorchiasis. Programmed gene editing confirmed that secreted parasite granulin induces hyperplasia
of the biliary epithelium and fibrosis during chronic infection, and that liver fluke granulin directly
contributes to morbidity of the hepatobiliary tract during both acute and chronic opisthorchiasis.
The impact of Ov-GRN-1 might emulate the action of interleukin IL 33, an epithelial mitogen for
cholangiocytes, in the development of CCA. IL-33 primes type two innate lymphoid cells to induce
proliferation of neighboring cholangiocytes by the release of IL-13 (Brindley and Loukas, 2017;
Li et al., 2014). The pathophysiological bioactivity of granulin warrants deeper investigation of its
role in fibrosis, including the influence on hepatic stellate cells, during liver fluke infection and chol-
angiocarcinogenesis (Guido et al., 1997; Yin et al., 2013; Gouveia et al., 2017; Rockey et al.,
2015).
The rigor of future gene editing investigations might be enhanced with the inclusion of additional
controls including parasites transfected with an otherwise functional vector that lacks target-specific
gRNA and/or a gRNA with a scaffold but without seed sequence and/or containing a seed sequence
without homology in the genome of O. viverrini. These additional controls would address non-tar-
get-specific effects of expression of Cas9 including on the genetic fitness of the genome-edited par-
asites (Cox et al., 2015; Kosicki et al., 2018; Ihry et al., 2018). Likewise, in addition to estimation
of gene-editing performance and efficiency of somatic cell gene-editing in this multicellular helminth
parasite using NGS-based (Shah et al., 2015; Canver et al., 2018; Albadri et al., 2017) and quanti-
tative PCR-based approaches (Shah et al., 2015; Yu et al., 2014), droplet digital PCR (ddPCR)-
based analysis should provide more sensitive detection and quantification of gene-editing manipula-
tions. The ddPCR approach can provide simultaneous assessment of both homology directed repair
and NHEJ, the repair pathways that resolve Cas9 catalyzed double-stranded breaks, and also investi-
gate multiple, simultaneous editing conditions at the target locus (Miyaoka et al., 2018). With
respect to Ov-GRN1 and its tissue site of expression, the anomaly between the marked knockdown
of transcript levels and the minority of genomes mutated by the programmed gene editing among
the total number of cells in this liver fluke, is amenable to deeper inquiry. Characterizing by immuno-
localization the site of expression in the parasite from hamsters infected with gene-edited NEJ and/
or the location of the gene editing plasmid after transfection of the liver fluke should be instructive.
The causative agent for many cancers remains obscure including non-liver fluke infection-associ-
ated CCA. By contrast, the principal risk factor in liver fluke-endemic regions is well established:
infection with O. viverrini and related parasites (IARC Working Group on the Evaluation of Carci-
nogenic Risks to Humans, 2012; Fedorova et al., 2017; Shin et al., 2010b). CRISPR/Cas9-based
gene editing and the hamster model of human opisthorchiasis utilized here (Sripa et al., 2007),
including genetic manipulation of the larval infective stage of the parasite, provide a facile, func-
tional genomics system to interrogate this host-parasite relationship and pathophysiology
(Hoffmann et al., 2014). In a related model, periductal fibrosis induced by the liver fluke infection
combined with ingestion of dimethylnitrosamine or similar nitric oxide carcinogen results in epithelial
hyperplasia, cholangiocyte proliferation and DNA damage, which culminates in CCA
(Thamavit et al., 1987; Maksimova et al., 2017). Investigation utilizing genome edited liver flukes,
mutated at loci encoding granulin or other parasite products can now proceed, including interaction
of liver fluke granulin with cholangiocyte signaling pathways that are frequently mutated during liver
fluke infection-induced CCA (Jusakul et al., 2017).
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Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Hamster Mesocricetus auratus,
Syrian golden
Mahidol
University,
Thailand
NA
Parasite
(liver fluke)
Opisthorchis viverrini,
adult development
stage
(Papatpremsiri et al., 2015;
Laha et al., 2007;
Sithithaworn et al., 1997;
Pinlaor et al., 2013)
NA Infective stage
metacercariae of
O. viverrini obtained
from naturally infected,
cyprinid freshwater fish
from Mukdahan and other
Isaan provinces, Thailand,
and used to infect hamsters.
Parasite
(liver fluke)
Opisthorchis viverrini,
metacercariae and
newly
excysted juveniles
(Papatpremsiri et al., 2015;
Laha et al., 2007;
Sithithaworn et al., 1997;
Pinlaor et al., 2013;
Papatpremsiri et al., 2016)
NA Infective stage metacercariae
of O. viverrini
obtained from naturally
infected, cyprinid
freshwater fish from
Isaan provinces,
Thailand.
Commercial
kit
GeneArt CRISPR
Nuclease Vector Kit
Invitrogen A21174
Serum Anti-Ov-GRN-1
rabbit serum
(Smout et al., 2009) NA
Antibody Alexa Fluor 594-
labeled anti-ACTA2
Abcam
(Capone et al., 2016;
Burwinkel et al., 2018)
ab202368
Commercial
reagent
Agencourt
AMPure XP beads
Beckman A63880
Commercial
reagent
GeneRead
Adaptors I Set A
Qiagen 180985
Commercial
kit
QIAseq 1-step
Amplicon Library Kit
Qiagen 180412
Commercial kit GeneRead Library
Quant Kit
Qiagen 180612
Human
cholangiocyte
cell line, H69
Cholangiocyte cell
line derived by SV
40 transformation
(Smout et al., 2015;
Grubman et al., 1994)
H69;
RRID: CVCL_8121
Commercial
kit
Picro Sirius Red Stain
Kit (Connective
Tissue Stain)
Abcam ab150681
Opisthorchis viverrini liver flukes
Metacercariae (MC) of O. viverrini were isolated from the naturally infected cyprinid fish by pepsin
digestion as described (Pinlaor et al., 2013). In brief, fishes were homogenized using an electric
blender, after which the homogenate was incubated for 120 min at 37˚C in 0.25% porcine pepsin,
1.5% HCl, 150mM NaCl. Subsequently, the digest was filtered sequentially through sieves of 1100,
350, 250 and 140 mm diameter pore size. After gravity sedimentation of the final filtrate, the aque-
ous supernatant was discarded, the MC-enriched sediment was washed once in 150 mM NaCl, and
the identity of MC as O. viverrini confirmed using a stereomicroscope. Batches of MC were stored in
150 mM NaCl at 4˚C. The newly excysted-juvenile flukes (NEJ) were liberated from MC by incubation
in 0.25% trypsin in 1 PBS supplemented with 2 200 U/ml penicillin, 200 mg/ml streptomycin
(Gibco) (2 Pen/Strep) for 5 min at 37˚C in 5% CO2 atmosphere, after which NEJ were separated
from the discarded cyst walls of the MC by mechanical passage through a 27G (insulin) needle
(Papatpremsiri et al., 2015; Papatpremsiri et al., 2016). Before use, NEJ were transferred into
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RPMI medium supplemented with 1% glucose, 2 g/l NaHCO3, 2 Pen/Strep, 1mM E-64 (Thermo
Fisher Scientific) for 60 min at 37˚C in 5% CO2 atmosphere.
To obtain the adult developmental stage of the liver fluke, Syrian golden hamsters (Mesocricetus
auratus) were infected by intragastric tube at 6–8 weeks of age with 50 MC per hamster (Sripa and
Kaewkes, 2002). The hamsters were maintained at the rodent facility of the Faculty of Medicine,
Khon Kaen University, Khon Kaen. Sixty days after infection, hamsters were euthanized, and the liver
flukes collected as described (Sripa and Kaewkes, 2002). The Animal Ethics Committee of Khon
Kaen University approved the study, approval number ACUC-KKU-61/60, which adhered to standard
guidelines of the National Research Council of Thailand for the Ethics of Animal Experimentation.
Vector and guide RNA targeting exon 1 of Ov-GRN-1
To edit the gene Ov-GRN-1 that encodes O. viverrini granulin-1 (6,287 bp, mRNA GenBank
FJ436341.1) (Smout et al., 2009; Young et al., 2014), online tools including CRISPR design, http://
crispr.mit.edu/ (Ran et al., 2013) and ChopChop, http://chopchop.cbu.uib.no/ (Labun et al., 2016;
Montague et al., 2014) were employed to design a single guide RNA (sgRNA) targeting exon 1 of
the Ov-GRN-1 gene at nucleotide position 1589–1608, 5’-GATTCATCTACAAGTGTTGA (Figure 1A
and B). The programmed cleavage site was predicted to be located at three residues upstream of a
CGG proto-spacer adjacent motif (PAM) sequence in exon 1 of Ov-GRN-1 (Figure 1B, Figure 1—
figure supplement 1B). A CRISPR/Cas9-encoding vector encoding this sgRNA under the control of
the mammalian U6 promoter and encoding Cas9 (with nuclear localization signal 1 and 2) driven by
the CMV promoter was assembled (GeneArt CRISPR Nuclease Vector Kit, Invitrogen), and termed
pCas-Ov-GRN-1 (Figure 1—figure supplement 1A). Escherichia coli TOP-10 competent cells were
transformed with pCas-Ov-GRN-1 after which the plasmid was recovered from cultures of a positive
clone (NucleoBond Xtra Midi, Macherey-Nagel GmbH, Germany). The nucleotide sequence of pCas-
Ov-GRN-1 was confirmed by Sanger direct cycle sequencing.
Transfection of liver flukes with pCas-Ov-GRN-1
Pools of 20 mature adult flukes were simultaneously subjected to transfection with 10 mg pCas-Ov-
GRN-1 plasmid DNA in ~500 ml RPMI-1640 (Sigma) by electroporation; all 20 flukes were included in
the same cuvette during electroporation. The electroporation was performed in 4 mm cuvettes (Bio-
Rad) with a single square wave pulse of 125 volts for 20 ms using a Gene Pulser Xcell (Bio-Rad)
(Papatpremsiri et al., 2015; Piratae et al., 2012). Flukes were then washed several times with 150
mM NaCl and an additional five times with RPMI-1640 containing 2 Pen/Strep. Flukes were cul-
tured in RPMI-1640 containing 2 Pen/Strep at 37˚C in 5% CO2 atmosphere (Papatpremsiri et al.,
2015; Piratae et al., 2012). Two control groups were included: wild-type (WT) mature flukes and
‘mock’ control flukes which were exposed to identical electroporation conditions with RPMI-1640
and 1 Pen/Strep in the absence of plasmid DNA. The adult flukes were observed and collected
after 1, 2, 3, 5, 7, 14 and 21 days of culture following pCas-Ov-GRN-1 transfection. RNA and protein
were extracted from individual flukes and Ov-GRN-1 mRNA expression was assessed by RT-qPCR
and Ov-GRN-1 protein expression was assessed by western blot. Mutations and/or insertions-dele-
tions (INDELs) resulting from CRISPR/Cas were estimated by two discrete types of analysis: 1) by Illu-
mina-based Next Generation Sequencing (NGS) (Shah et al., 2015; Albadri et al., 2017); 2) by
CRISPR efficiency estimation (Shah et al., 2015; Yu et al., 2014; Yang et al., 2017), a method based
on the differences in RT-qPCR efficiencies between amplification of the WT and mutant sequence
with a primer spanning the targeted mutation site.
MC and NEJ (750 larvae per cuvette) were subjected to square wave electroporation in the pres-
ence of pCas-Ov-GRN-1 pDNA as described above for adult flukes. The larvae were washed as
above and cultured in RPMI complete medium (2 Pen/Strep) at 37˚C in 5% CO2 atmosphere. Tran-
script levels for Ov-GRN-1 on days 1, 2, 3, and 5 after transfection were ascertained by RT-qPCR, as
above.
Extraction of nucleic acids
RNA was extracted from pooled or individual transfected flukes using the TRIzol reagent (Invitro-
gen). Concentration of RNA was estimated by absorbance at 260 nm using a NanoVue spectropho-
tometer. Genomic DNA was extracted from individual adult flukes using the QIAamp DNA Mini Kit
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(Qiagen). A dual RNA and DNA extraction was used for individual worms at day 60 after infection of
hamsters with Ov-GRN-1 gene-edited NEJ, using RNAzol RT and DNAzol (Molecular Research Cen-
ter, Inc.) (Chan et al., 2014; Chen et al., 2010). In brief, each worm was homogenized in RNAzol RT
using a motorized pestle, the DNA and protein from the lysate was precipitated using DNAse-
RNAse-free water. The aqueous phase (top) was transferred into isopropanol to precipitate the
RNA. The DNA/protein pellet was resuspended in DNAzol, and DNA extracted as per the manufac-
turer’s instructions. Expression levels of Ov-GRN-1 in total RNA recovered from individual liver flukes
were determined.
To assess the performance of the gene editing approach, following necropsy of hamsters and
recovery of the liver flukes, the adult worms were assigned to one of three phenotypes based on the
levels of Ov-GRN-1 transcript knockdown, low (L), moderate (M) or high (H), as follows: L, 100%
relative to WT mean (low efficiency of programmed genome editing), group termed LDOv-GRN-1;
M, >10 to<100% relative to WT mean, group termed MDOv-GRN-1; and H, 10% relative to WT
mean, group termed HDOv-GRN-1. Pools of genomic DNAs from flukes, which had been assigned to
each of the L, M and H groups of Ov-GRN1 transcript knockdown levels, were quantified for effi-
ciency of CRISPR/Cas9-programmed gene editing in terms of mutation levels by qPCR and Illumina-
based deep sequencing (below) (Yang et al., 2017; Vasquez et al., 2018). The data for the pooled
samples from each group are based on a single Illumina run, that is n = 1 sample for each of the L,
M and H genomic DNA pools.
Quantitative real-time PCR
Complementary DNA (cDNA) was synthesized from parasite total RNA using an iScript cDNA syn-
thesis kit (Thermo Fisher Scientific) prior to proceeding with reverse transcription quantitative real-
time PCR (RT-qPCR). RT-qPCR was performed with biological triplicate samples using a SYBR Green
kit (Takara Bio USA, Inc., Mountain View, CA) in a thermal cycler (Light Cycler 480 II, Roche Diagnos-
tics GmbH, Mannheim, Germany). Each RT-qPCR reaction consisted of 7.5 ml SYBR Green Master
Mix, 0.5 ml (10 mM) each of specific forward and reverse primers for Ov-GRN-1 (Figure 1B) (forward
primer, Ov-GRN-1-RT-F: 5’-GGGATCGGTTAGTCTAATCTCC and reverse primer, Ov-GRN1-RT-R:
5’-GATCATGGGGGTTCACTGTC), amplifying 359 base pairs (bp) of the product (nt 7365 of O.
viverrini granulin-1 mRNA, GenBank FJ436341.1), 2 ml of cDNA and distilled water to a final volume
of 15 ml. The thermal cycle was a single initiation cycle at 95˚C for 3 min followed by 40 cycles of
denaturation at 95˚C for 30 s, annealing at 55˚C for 30s, extension at 72˚C for 45s and a final exten-
sion at 72˚C for 10 min. The endogenous actin gene (GenBank EL620339.1) was used as a house-
keeping control (Papatpremsiri et al., 2015; Piratae et al., 2012; Chaiyadet et al., 2017) (forward
primer, Ov-actin-F: 5’-AGCCAACCGAGAGAAGATGA and reverse primer Ov-actin-R: 5’-ACC
TGACCATCAGGCAGTTC). The fold change in Ov-GRN-1 transcripts was calculated by the 2(-DDCt)
method using Ov-actin for normalization (Papatpremsiri et al., 2015; Piratae et al., 2012;
Schmittgen and Livak, 2008). Means and standard deviations were calculated and means compared
by two-way ANOVA using GraphPad Prism software.
Rabbit anti-Ov-GRN-1 antiserum and western blot analysis
One milligram of adjuvanted, recombinant Ov-GRN1 protein (Smout et al., 2009; Strannega˚rd and
Yurchision, 1969) was subcutaneously injected into an outbred New Zealand White rabbit. The rab-
bit was boosted twice with 500 mg of adjuvanted protein, and 2 weeks after the last booster the rab-
bit was euthanized after which blood was collected by cardiac puncture (Animal Ethics Committee,
Khon Kaen University, approval no ACUC-KKU-61/60; see above). Ov-GRN-1 protein levels were
determined by western blot using rabbit anti-recombinant Ov-GRN-1 antiserum. The adult flukes
from either WT or DOv-GRN-1 groups were collected individually at days 1, 2, 3, 5, 7, 14 and 21
after electroporation (three flukes per group). Groups of three flukes were homogenized by sonica-
tion (Sonics and Materials) in 1 PBS with alternating pulses of 5s duration (with 5s pause between
pulses) for 45 s at 4˚C. The homogenate was clarified by centrifugation at 13,000 g for 30 min at
4˚C, after which the supernatant was stored at  20˚C. Protein concentration of fluke homogenates
was determined by the Bradford assay. Homogenates were subjected to SDS-PAGE (15%) electro-
phoresis, and the resolved proteins transblotted to nitrocellulose membrane using a Mini Trans-Blot
Cell (Bio-Rad). Membrane strips containing 2 mg of total protein were washed with 0.5% Tween-20
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in 1 PBS (PBST), blocked with 5% skimmed milk in PBST for 60 min and probed with rabbit anti-
Ov-GRN-1 serum or pre-immunization serum, diluted 1:50 with 1% skimmed milk in PBST, for 2 hr
with gentle agitation. After washing, the strips were probed with horseradish peroxidase (HRP)-goat
anti-rabbit IgG (Invitrogen), diluted 1:1000 in antibody buffer, for 60 min. The strips were washed,
signals detected using enhanced chemiluminescence (ECL) substrate (GE Healthcare Life Sciences)
and imaged using an Image Quant LAS 4000 mini (GE Healthcare Life Sciences). As a control protein
also derived from the tegument of O. viverrini flukes, we also assessed the protein expression levels
of Ov-TSP-2 by western blot using a specific antibody raised to the recombinant protein
(Chaiyadet et al., 2017). Relative protein expression levels as established by western blot were mea-
sured by densitometry using Image J, https://imagej.nih.gov/ij/download.html. Levels of protein
expressed between groups were compared by independent Student’s t-tests.
CRISPR/Cas efficiency and mutation levels estimated by quantitative
PCR
Adult flukes were collected on days 1, 2, 3, 5, 7, 14 and 21 after pCas-Ov-GRN-1 transfection. The
genome of each fluke was investigated for mutation(s) expected to have resulted from the repair by
NHEJ events following the sgDNA programmed double stranded break (DSB) of the Ov-GRN-1
locus by Cas9. For analysis of gDNA from individual adult liver flukes recovered from infected ham-
sters, we performed a qPCR assay to detect and quantify the frequencies of newly induced muta-
tions. The approach employed two pairs of primers for the target locus, with one putative amplicon
extending beyond the putative INDEL site and the other overlapping it, as described (Yu et al.,
2014). The primers were named Ov-GRN-1-OUT-F, Ov-GRN-1-OVR-F, and Ov-GRN-1-reverse (OUT/
OVR-R), respectively. The primer pair of Ov-GRN-1-OUT-F (5’-TTCGAGATTCGGTCAGCCG) and
OUT/OVR-R (5’-TTGGTCGGCCAGTATGTTCG) amplified the fragment flanking and spanning the
DSB (1,496–2,312 nt), whereas the primer pair Ov-GRN-1-OVR-F (5’-CAAGTGTTGACGGTGA
TTTCACTT) and OUT/OVR-R amplified a region overlapping the DSB (1599–2312) (Figure 1B).
Whereas both primer pairs exhibited equivalent amplification efficiencies with the genomic DNA
template from WT flukes, the Ov-GRN-1-OVR-F and OUT/OVR-R primer pair was mutation sensitive,
whereas the other pair was not. The OUT and OVR amplicons were 817 and 714 bp in size, respec-
tively, using the following PCR conditions: 7.5 ml of SYBR Green Master Mix (TaKaRa Perfect Real-
time Kit), 0.5 ml (0.4 mM) of each primer, 10 ng/ml of gDNA and distilled water to 15 ml. The thermal
cycles included initiation for one cycle at 95˚C, 3 min followed by 40 cycles of denaturation at 95˚C,
30s, annealing at 55˚C, 30s, extension at 72˚C, 45s, and a final extension at 72˚C for 10 min. The
SYBR green signal was read at each annealing cycle and reported as threshold cycle (Ct). Efficiency
of programmed CRISPR/Cas editing was estimated as the ratio of CtOUT:CtOVR from the experimen-
tal group compared with CtOUT:CtOVR of the control group, as described (Yu et al., 2014). The
CtOUT:CtOVR ratio from the control group would equal ‘1’ (CRISPR efficiency = 0) since there was dif-
ference in Ct values from the OUT and OVR primers. By contrast, the OVR primer can be anticipated
to be inefficient when compared to the OUT primer for the experimental group, and hence the
CtOUT:CtOVR likely would be <1. Here, we calculated percent mutation indirectly by subtraction of
the CRISPR/Cas9 efficiency value from ‘1’, as indicated (Yu et al., 2014; Sentmanat et al., 2018).
EfficiencyðFÞ ¼
AveragectOUT
AveragectOVR
CRISPR=Cas9efficiency¼
FDOv gm 1
Fcontrol
ð100Þ
Mutationrate¼ 100% CRISPR=Cas9efficiency
Genomic DNAs from flukes recovered from hamsters 60 days after infection with CRISPR/Cas9-
treated NEJ, and which had been assigned to the low (L), moderate (M) or high (H) groups based on
knockdown levels of Ov-GRN-1 transcripts, were pooled by group. The L, M and H groups were
assessed and scored for efficiency of CRISPR/Cas9-programmed gene editing in terms of mutation
levels by qPCR, as described above.
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Targeted Amplicon libraries, Illumina-based sequencing
Several Illumina NGS libraries were constructed. First, for analysis of programmed editing of adult
flukes that were subjected to gene editing manipulation and subsequently cultured in vitro, genomic
DNAs were extracted from the Ov-GRN-1 gene-edited adult liver flukes at each of 7, 14 and 21 days
after transfection. A pool of gDNA was prepared from 15 of these flukes, from five worms from each
time point. Second, gDNAs were pooled from 7 to 10 worms from each of the L, M, and H groups
of DOv-GRN-1 worms (25 worms in total) (Figure 5A and B) and also a gDNA pool from 25 control
non-gene-edited WT worms. Targeted amplicon NGS libraries were constructed from each of these
of gDNA pools. In each case, an amplicon of 173 bp in size that spanned the DSB was amplified
using Ov-GRN-1 MiSeq-F primer 5’-TTCGAGATTCGGTCAGCCG (position 1496–1514 nt) and Ov-
GRN-1 MiSeq-R primer 5’-GCACCAACTCGCAACTTACA (position 1649–1668 nt) (Figure 1B). These
amplicons were purified (Agencourt AMPure XP beads, Beckman) and ligated with Gene Read
Adaptors Set A (Qiagen) and Illumina compatible adaptor(s) and barcode(s) using QIAseq 1-step
Amplicon library kit (Qiagen). The libraries were quantified using the GeneRead Library Quant Kit
(Qiagen) with Illumina index/barcode specific primers, and concentration of the libraries established
using standard libraries provided in the kit. Illumina NGS was performed by GENEWIZ (South Plain-
land, NJ). Index/adaptor and primer out sequences were trimmed from the reads. Analysis of the
sequenced reads using the SnapGene (GSL Biotech LLC) and the CRISPResso software (https://
github.com/lucapinello/CRISPResso) suites was carried out to validate and characterize programmed
mutations of the alleles, including assessment of NHEJ-induced INDELS as insertions, deletions and/
or substitutions (Canver et al., 2018; Pinello et al., 2016). The sequences of the alleles were com-
pared to the reference sequence represented by the target amplicon of the WT Ov-GRN-1 gene
(GenBank FJ436341.1) and to the reads from the control worms for the flukes derived from infection
of hamsters with gene-edited NEJ. Of these two analysis methods for performance of CRISPR/Cas9
gene-editing, the qPCR approach (Yu et al., 2014) is quick and inexpensive in comparison to the tar-
geted amplicon NGS approach (Canver et al., 2018; Shalem et al., 2015). However, the latter
approach provides more detailed characterization of the events including the types and frequencies
of the INDELS, and is more accurate (Sentmanat et al., 2018).
Cell proliferation and wound healing assays
To evaluate the effect of Ov-GRN-1 gene editing on liver fluke-driven proliferation of human cholan-
giocytes, motile WT or DOv-GRN-1 adult flukes were co-cultured with cells of the human cholangio-
cyte cell line H69 in 24-well Trans-well plates (three wells per group) (Papatpremsiri et al., 2015)
containing a 4 mm pore size membrane separating the upper and lower chambers (Corning). In brief,
15,000 H69 cells were seeded into the lower chamber of the plate and cultured with complete
medium containing DMEM/F12 supplemented with 1  antibiotic, 10% fetal bovine serum, 25 mg/ml
adenine, 5 mg/ml insulin, 1 mg/ml epinephrine, 8.3 mg/ml holo-transferrin, 0.62 mg/ml hydrocortisone,
1.36 mg/ml T3, and 10 ng/ml epidermal growth factor (Ninlawan et al., 2010) for 24 hr, after which
the cells were fasted for 4–6 hr in medium supplemented with only one twentieth of the growth fac-
tor content of complete medium. Five viable O. viverrini adult flukes that had been transfected (or
not) with pCas-Ov-GRN-1 pDNA in a total of 500 ml of RPMI (or medium alone) were placed into the
upper chamber of each well. The number of cells in each well was determined at days 1, 2, and 3
using 1  PrestoBlue cell viability reagent (Invitrogen) (Tynan et al., 2012) added to cells at 37˚C in
5% CO2 atmosphere for up to 60 min. Cell number was determined at 570 nm and calculated from a
standard curve before transforming into relative growth compared to control groups. Cell prolifera-
tion assays were carried out in triplicate.
To assess the effect of Ov-GRN-1 knockout on in vitro wound healing, 300,000 cholangiocytes in
monolayers were grown in 6-well Trans-well plates with a 4 mm pore size. These cells were cultured
in complete media for 2 days at 37˚C in 5% CO2 atmosphere then transferred to incomplete media
overnight. Monolayers in each well were scratched using a sterile 200 ml autopipette tip
(Papatpremsiri et al., 2015; Smout et al., 2015; Liang et al., 2007) and washed with 1 PBS twice
to remove disconnected cells or debris. Ten transfected adult or control flukes were added to the
upper chamber of the Transwell plate containing the wounded cell monolayer in the lower chamber.
The rate of wound closure was measured at 0, 12, 24 and 36 hr, respectively. Transwell plates were
imaged using an inverted microscope (Nikon) and images of all groups were captured at all-time
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points quantitatively using Adobe Photoshop CS6. The distances between different sides of the cell
monolayer scratch were measured by drawing a line in the middle of the scratch on the captured
image (Papatpremsiri et al., 2015; Smout et al., 2015; Liang et al., 2007; Smout et al., 2011). The
analysis of monolayer wound healing was repeated three times.
H69 cells (Smout et al., 2015; Grubman et al., 1994) were authenticated using STR profiling by
PCR by ATCC and were confirmed in our laboratory to be Mycoplasma-free using the Lookout
Mycoplasma PCR detection kit (Sigma-Aldrich).
Infection of hamsters with Ov-GRN-1 gene-edited NEJs and
histopathological assessment of hepatobiliary lesions
Thirty male Syrian golden hamsters, 6–8 weeks of age, were obtained from the Animal Unit, Faculty
of Medicine, Khon Kaen University (approval number ACUC-KKU-61/60). The hamsters were ran-
domly divided into three groups of 10 animals per group: uninfected control, infected with WT
flukes, and infected with DOv-GRN-1 flukes. Each hamster was infected with 100 active NEJs through
intragastric intubation; the uninfected control group was fed normal saline solution instead of NEJ
(Sripa and Kaewkes, 2002). Hamsters (five animals per cage) were maintained under conventional
conditions and fed a stock diet (C.P. Ltd., Thailand) and water ad libitum until they were euthanized
(Sripa and Kaewkes, 2002). Following euthanasia, five hamsters from each group were necropsied
for histopathological assessment of the hepatobiliary tract at days 14 and 60 post-infection
(Sripa and Kaewkes, 2002). The hamsters were euthanized by overdose of anesthesia with diethyl
ether. Subsequently, blood was obtained by cardiac puncture and the livers were removed. Fluke
numbers were counted from two livers of both WT and DOv-GRN-1 groups at day 60 post-infection
and compared using an unpaired two-tailed t-test. The left and right lobes of the liver from five ham-
sters were dissected, cross-sectioned, and each lobe was divided into three parts. The liver frag-
ments were fixed in 10% buffered formalin and stored overnight at 4˚C before processing. Formalin-
fixed liver was dehydrated through an ethanol series (70, 95, and 100%), cleared in xylene, and
embedded in paraffin. Paraffin embedded sections of 4 mm thickness, cut by microtome, were
stained with hematoxylin and eosin (H&E) or Picro-Sirius Red, or probed with anti-ACTA2 antibodies,
and analyzed for pathologic changes (below).
Biliary hyperplasia
H&E staining was used to assess pathological changes. The sections were deparaffinized in 100%
xylene, rehydrated through a descending series of alcohol, stained with H&E for 5 min, dehydrated
in an ascending series of alcohol, cleared with 100% xylene, mounted in Permount medium on a
glass slide, and slides were dried overnight at 37˚C and photographed under light microscopy.
Images (200) from H&E-stained sections from five hamsters infected with WT flukes, five hamsters
infected with DOv-GRN-1 flukes, and five uninfected hamsters were assessed. Thickness (width) of
the bile duct epithelium from each thin liver section was measured with ImageJ at eight equidistant
positions around the bile duct. To compensate for outliers, the median width for each bile duct was
used for the analysis. The two-way ANOVA Holm-Sidak multiple comparisons test was used to com-
pare groups at each time point.
Fibrosis
Two stains were used separately to assess biliary fibrosis. First, sections were stained with Picro-Sir-
ius Red (Abcam, Cambridge Science Park, UK). Sufficient Picro-Sirius Red solution was applied to
completely cover the tissue sections on the slide, the stained slide was incubated at ambient tem-
perature for 60 min, rinsed in two changes of acetic acid solution and dehydrated through two
changes of absolute ethanol. Slides were cleared with 100% xylene, mounted in Per-mount, dried
overnight at 37˚C and photographed by light microscopy to document collagen surrounding the bile
ducts. ImageJ was used to auto-color balance the images using the macro by Vytas Bindokas at
https://digital.bsd.uchicago.edu/docs/imagej_macros/_graybalancetoROI.txt followed by application
of the MRI fibrosis tool to quantify percentage area of fibrosis (red-stain) at default settings (red 1:
0.148, green 1: 0.772, blue 1: 0.618, red 2: 0.462, green 2: 0.602, blue 2: 0.651, red 3: 0.187, green
3: 0.523, blue 3: 0.831) (Pereira, 2016). Twenty discrete images (200) stained with Picro-Sirius Red
from each hamster (five animals per treatment group) were assessed, that is 100 images per group.
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Given a broad range of values among groups, comparison of the groups was undertaken using the
Kruskal-Wallis with Dunn’s multiple comparisons test.
Expression level of smooth muscle alpha-actin (a-SMA; ACTA2) also was assessed as a surrogate
for fibrosis. Liver sections from hamsters at 60 days post-infection were deparaffinized 3 times with
100% xylene, 5 min each. Sections were rehydrated with an ascending series of ethanol; 100%, three
times, 3 min each, 95%, three times, 3 min each, 70% for 3 min, followed by thorough washing in
tap water for 5 min, distilled water for 5 min, and 1 PBS for 5 min. Thereafter, slides were incu-
bated in citrate buffer 0.1 M, pH 6.0 (citric acid, anhydrous, 0.06 M, sodium citrate dihydrate, 0.04
M) at 110˚C for 5 min, allowed to cool at room temperature for 20 min, and then washed in 1 PBS,
three times, 5 min each. Thereafter, the sections were blocked with 5% bovine serum albumin (BSA)
for 30 min in a humidified chamber and washed in three times in 1 PBS, 3 min each with occasional
shaking. The slides were probed with Alexa Fluor 594-labeled anti-ACTA2 antibody (Abcam) diluted
1:200 in 1% BSA in PBST, 18 hr at 4˚C in a humidified atmosphere. Lastly, slides were washed as
above, mounted in glycerol, diluted 1:4 with 1  PBS, and examined under bright and fluorescent
lights (Zeiss Axio Observer; AxioVision SE64 Rel. 4.9.1 software, Jena, Germany). Images with a bile
duct containing a fluke were selected and ImageJ used to define regions adjacent to the epithelium
that excluded potential blood vessels (ovate structures). Three sites, free of bile ducts and blood
vessels, were selected at random in order to establish levels of background fluorescence, each com-
prising 5–10% of the image. The fluorescence intensity of the biliary epithelium was measured and
blanked against the mean of the three background readings and reported as mean intensity per cm2
at 300 pixels per inch (PPI). Twenty-five to 30 discrete images of bile ducts per treatment group
(three hamsters) were assessed. Zero values from the uninfected group were assigned a value of 1
to enable use of a log axis. The groups were compared using one-way ANOVA with Holm-Sidak mul-
tiple comparisons test.
Biological and technical replicates, statistics
These biological replicates represented parallel measurements of biologically discrete samples in
order to capture any random biological variation. Technical replicates were undertaken as well; these
represented repeated measurements of the same sample undertaken as independent measurements
of the random noise associated with the investigator, equipment or protocol.
Means for experimental groups were compared to control by one or two ways ANOVA and
where appropriate, by Student’s t-test (GraphPad Prism, La Jolla, CA). Values for p of 0.05 were
considered to be statistically significant.
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